NRIX
Nurix Therapeutics Inc
NASDAQ: NRIX · HEALTHCARE · BIOTECHNOLOGY
$16.70
+0.54% today
Updated 2026-04-30
Market cap
$1.72B
P/E ratio
—
P/S ratio
23.93x
EPS (TTM)
$-3.17
Dividend yield
—
52W range
$8 – $23
Volume
1.1M
Nurix Therapeutics Inc (NRIX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+4.7%
Last 4 quarters
Revenue YoY growth
-66.1%
Most recent quarter
EPS YoY growth
-17.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.6%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-9.4%
2026-01-28
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-14 | $-0.79 | +4.8% | $15.91 | $16.97 | +6.7% |
| 2026-01-28 | $-0.82 | +10.9% | $19.41 | $17.59 | -9.4% |
| 2025-10-09 | $-1.03 | -24.1% | $9.98 | $9.76 | -2.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-02-28 | $-0.83 | $-0.79 | +4.8% | $6.25M | -66.1% |
| 2025-11-30 | $-0.92 | $-0.82 | +10.9% | $13.58M | +2.2% |
| 2025-08-31 | $-0.83 | $-1.03 | -24.1% | $7.89M | -37.3% |
| 2025-05-31 | $-0.71 | $-0.52 | +27.2% | $44.06M | +264.3% |
| 2025-02-28 | $-0.76 | $-0.67 | +12.0% | $18.45M | +11.3% |
| 2024-11-30 | $-0.67 | $-0.75 | -12.1% | $13.28M | -12.4% |
| 2024-08-31 | $-0.71 | $-0.67 | +5.6% | $12.59M | -31.8% |
| 2024-05-31 | $-0.63 | $-0.71 | -12.7% | $12.09M | -60.6% |
| 2024-02-29 | $-0.80 | $-0.76 | +5.0% | $16.59M | — |
| 2023-11-30 | $-0.57 | $-0.77 | -35.1% | $15.16M | — |
| 2023-08-31 | $-0.76 | $-0.68 | +10.5% | $18.47M | — |
| 2023-05-31 | $-0.56 | $-0.45 | +19.6% | $30.68M | — |
Frequently asked questions
Has Nurix Therapeutics Inc beaten earnings estimates?
Nurix Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +4.7% over the last 4 quarters.
How does NRIX stock react to earnings?
NRIX stock has moved an average of -1.6% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Nurix Therapeutics Inc's revenue growth rate?
Nurix Therapeutics Inc reported year-over-year revenue growth of -66.1% in its most recent quarter, with EPS growing -17.9% year-over-year.